SNAP Life Sciences
PrivateLast Round
Series A
Feb 6, 2025
Total Funding Raised
$10M
Company Overview
SNAP Life Sciences is a biotechnology and pharmaceutical technology company that provides an AI-driven platform for drug asset valuation, portfolio optimization, and the exchange of intellectual property.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SNAP Life Sciences Comparables
Compare SNAP Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prudentia Sciences | 88% | |
| PhaseFolio | 79% | |
| DealForma | 79% | |
SNAP Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 6, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 13, 2025
Grew 30% QoQ, from 10 to 13 employees.
- Aug 23, 2025
Grew 43% QoQ from 7 to 10 employees.
SNAP Life Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SNAP Life Sciences's valuation, stock price, and market status.